Advertisement

Vitamin B2 intake reduces the risk for colorectal cancer: a dose–response analysis

  • Shuai Ben
  • Mulong Du
  • Gaoxiang Ma
  • Jianhua Qu
  • Liyang Zhu
  • Haiyan Chu
  • Zhengdong Zhang
  • Yuan Wu
  • Dongying Gu
  • Meilin Wang
Original Contribution

Abstract

Purpose

Several epidemiological studies have assessed the ability of vitamin B2 to prevent colorectal cancer (CRC), but the results are controversial results. We conducted a dose–response meta-analysis to investigate the association between vitamin B2 and CRC risk.

Methods

We searched the PubMed and EMBASE database until January 3, 2018 to identify relevant studies. The pooled relative risks (RRs) with the corresponding 95% confidence intervals (CIs) were calculated using a random-effects model or fixed-effects model. The dose–response relationship was assessed by restricted cubic splines.

Results

A total of 14 studies reporting vitamin B2 intake and two studies reporting blood vitamin B2 concentration, comprising 14,934 cases and 1593 cases, respectively, were included in the meta-analysis. Vitamin B2 intake was inversely associated with CRC risk (RR = 0.87; 95% CI 0.81–0.93). Similar results were found for total vitamin B2 intake from diet and supplements (RR = 0.86; 95% CI 0.78–0.94) and dietary vitamin B2 intake (RR = 0.89, 95% CI 0.82–0.98) in subgroup analyses. The dose–response model indicated a non-linear trend, and CRC risk was reduced by 10% when vitamin B2 intake increased to 5 mg/day. In addition, high blood concentrations of vitamin B2 could also reduce the CRC risk (RR = 0.74; 95% CI 0.59–0.92).

Conclusions

This dose–response analysis indicates that vitamin B2 intake is inversely associated with CRC risk. The inverse association may also exist between blood vitamin B2 concentration and CRC risk. These results suggest the importance of vitamin B2 intake in the prevention of CRC.

Keywords

Colorectal cancer Vitamin B2 Dose–response Meta-analysis 

Notes

Acknowledgements

Conception and design: Meilin Wang, Dongying Gu, and Yuan Wu; Development of methodology: Shuai Ben, Mulong Du, and Gaoxiang Ma; Acquisition of data: Haiyan Chu and Liyang Zhu; Administrative, technical, or material support: Jianhua Qu and Zhengdong Zhang; Study supervision: Meilin Wang, Dongying Gu, and Yuan Wu.

Funding

This work was supported by the National Key R&D Program of China (2017YFC0908200), the National Natural Science Foundation of China (81773516), Distinguished Young Scholars of Nanjing (JQX13005), the Qinlan Project of Jiangsu (Meilin Wang), and the Priority Academic Program Development of Jiangsu Higher Education Institutions (Public Health and Preventive Medicine).

Compliance with ethical standards

Conflict of interest

The authors declare that they have no conflict of interest.

Supplementary material

394_2018_1702_MOESM1_ESM.docx (25 kb)
Supplementary material 1 (DOCX 25 KB)

References

  1. 1.
    Parkin DM (2001) Global cancer statistics in the year 2000. Lancet Oncol 2(9):533–543.  https://doi.org/10.1016/s1470-2045(01)00486-7 CrossRefGoogle Scholar
  2. 2.
    Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A (2015) Global cancer statistics, 2012. CA Cancer J Clin 65(2):87–108.  https://doi.org/10.3322/caac.21262 CrossRefGoogle Scholar
  3. 3.
    Arnold M, Sierra MS, Laversanne M, Soerjomataram I, Jemal A, Bray F (2017) Global patterns and trends in colorectal cancer incidence and mortality. Gut 66(4):683–691.  https://doi.org/10.1136/gutjnl-2015-310912 CrossRefGoogle Scholar
  4. 4.
    Knai C, Suhrcke M, Lobstein T (2007) Obesity in Eastern Europe: an overview of its health and economic implications. Econ Human Biol 5(3):392–408.  https://doi.org/10.1016/j.ehb.2007.08.002 CrossRefGoogle Scholar
  5. 5.
    Botteri E, Iodice S, Bagnardi V, Raimondi S, Lowenfels AB, Maisonneuve P (2008) Smoking and colorectal cancer: a meta-analysis. JAMA 300(23):2765–2778.  https://doi.org/10.1001/jama.2008.839 CrossRefGoogle Scholar
  6. 6.
    Song M, Garrett WS, Chan AT (2015) Nutrients, foods, and colorectal cancer prevention. Gastroenterology 148(6):1244–1260.e1216.  https://doi.org/10.1053/j.gastro.2014.12.035 CrossRefGoogle Scholar
  7. 7.
    Turati F, Rossi M, Pelucchi C, Levi F, La Vecchia C (2015) Fruit and vegetables and cancer risk: a review of southern European studies. Br J Nutr 113(Suppl 2):S102–110.  https://doi.org/10.1017/S0007114515000148 Google Scholar
  8. 8.
    Powers HJ (2003) Riboflavin (vitamin B-2) and health. Am J Clin Nutr 77(6):1352–1360CrossRefGoogle Scholar
  9. 9.
    Rivlin RS (1973) Riboflavin and cancer: a review. Cancer Res 33(9):1977–1986Google Scholar
  10. 10.
    Williams EA (2012) Folate, colorectal cancer and the involvement of DNA methylation. Proc Nutr Soc 71(4):592–597.  https://doi.org/10.1017/s0029665112000717 CrossRefGoogle Scholar
  11. 11.
    Strohle A, Wolters M, Hahn A (2005) Folic acid and colorectal cancer prevention: molecular mechanisms and epidemiological evidence (Review). Int J Oncol 26(6):1449–1464Google Scholar
  12. 12.
    La Vecchia C, Braga C, Negri E, Franceschi S, Russo A, Conti E, Falcini F, Giacosa A, Montella M, Decarli A (1997) Intake of selected micronutrients and risk of colorectal cancer. Int J Cancer 73(4):525–530CrossRefGoogle Scholar
  13. 13.
    Sun Z, Zhu Y, Wang PP, Roebothan B, Zhao J, Zhao J, Dicks E, Cotterchio M, Buehler S, Campbell PT, McLaughlin JR, Parfrey PS (2012) Reported intake of selected micronutrients and risk of colorectal cancer: results from a large population-based case–control study in Newfoundland, Labrador and Ontario, Canada. Anticancer Res 32(2):687–696Google Scholar
  14. 14.
    Shrubsole MJ, Yang G, Gao Y-T, Chow WH, Shu XO, Cai Q, Rothman N, Gao J, Wagner C, Zheng W (2009) Dietary B vitamin and methionine intakes and plasma folate are not associated with colorectal cancer risk in Chinese women. Cancer Epidemiol Prev Biomark 18(3):1003–1006CrossRefGoogle Scholar
  15. 15.
    Jedrychowski W, Steindorf K, Popiela T, Wahrendorf J, Tobiasz-Adamczyk B, Kulig J, Penar A (2001) Risk of colorectal cancer from alcohol consumption at lower vitamin intakes. A hospital-based case–control study in Poland. Rev Environ Health 16(3):213–222CrossRefGoogle Scholar
  16. 16.
    Otani T, Iwasaki M, Hanaoka T, Kobayashi M, Ishihara J, Natsukawa S, Shaura K, Koizumi Y, Kasuga Y, Yoshimura K, Yoshida T, Tsugane S (2005) Folate, vitamin B6, vitamin B12, and vitamin B2 intake, genetic polymorphisms of related enzymes, and risk of colorectal cancer in a hospital-based case–control study in Japan. Nutr Cancer 53(1):42–50.  https://doi.org/10.1207/s15327914nc5301_5 CrossRefGoogle Scholar
  17. 17.
    Liu Y, Yu QY, Zhu ZL, Tang PY, Li K (2015) Vitamin B2 intake and the risk of colorectal cancer: a meta-analysis of observational studies. Asian Pac J Cancer Prev 16(3):909–913CrossRefGoogle Scholar
  18. 18.
    Stang A (2010) Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol 25(9):603–605CrossRefGoogle Scholar
  19. 19.
    DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Controll Clin Trials 7(3):177–188CrossRefGoogle Scholar
  20. 20.
    Mantel N, Haenszel W (1959) Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 22(4):719–748Google Scholar
  21. 21.
    Zhang J, Yu KF (1998) What’s the relative risk? A method of correcting the odds ratio in cohort studies of common outcomes. JAMA 280(19):1690–1691CrossRefGoogle Scholar
  22. 22.
    Higgins JP, Thompson SG, Deeks JJ, Altman DG (2003) Measuring inconsistency in meta-analyses. BMJ 327(7414):557–560.  https://doi.org/10.1136/bmj.327.7414.557 CrossRefGoogle Scholar
  23. 23.
    Hedges LV, Pigott TD (2001) The power of statistical tests in meta-analysis. Psychol Methods 6(3):203–217CrossRefGoogle Scholar
  24. 24.
    Higgins JP, Thompson SG (2004) Controlling the risk of spurious findings from meta-regression. Stat Med 23(11):1663–1682.  https://doi.org/10.1002/sim.1752 CrossRefGoogle Scholar
  25. 25.
    Harrell FE Jr, Lee KL, Pollock BG (1988) Regression models in clinical studies: determining relationships between predictors and response. J Natl Cancer Inst 80(15):1198–1202CrossRefGoogle Scholar
  26. 26.
    Orsini N, Li R, Wolk A, Khudyakov P, Spiegelman D (2012) Meta-analysis for linear and nonlinear dose-response relations: examples, an evaluation of approximations, and software. Am J Epidemiol 175(1):66–73.  https://doi.org/10.1093/aje/kwr265 CrossRefGoogle Scholar
  27. 27.
    Greenland S, Longnecker MP (1992) Methods for trend estimation from summarized dose-response data, with applications to meta-analysis. Am J Epidemiol 135(11):1301–1309CrossRefGoogle Scholar
  28. 28.
    Thornton A, Lee P (2000) Publication bias in meta-analysis: its causes and consequences. J Clin Epidemiol 53(2):207–216CrossRefGoogle Scholar
  29. 29.
    Egger M, Davey Smith G, Schneider M, Minder C (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315(7109):629–634CrossRefGoogle Scholar
  30. 30.
    de Vogel S, Dindore V, van Engeland M, Goldbohm RA, van den Brandt PA, Weijenberg MP (2008) Dietary folate, methionine, riboflavin, and vitamin B-6 and risk of sporadic colorectal cancer. J Nutr 138(12):2372–2378.  https://doi.org/10.3945/jn.108.091157 CrossRefGoogle Scholar
  31. 31.
    Zschabitz S, Cheng TY, Neuhouser ML, Zheng Y, Ray RM, Miller JW, Song X, Maneval DR, Beresford SA, Lane D, Shikany JM, Ulrich CM (2013) B vitamin intakes and incidence of colorectal cancer: results from the Women’s Health Initiative Observational Study cohort. Am J Clin Nutr 97(2):332–343.  https://doi.org/10.3945/ajcn.112.034736 CrossRefGoogle Scholar
  32. 32.
    Bassett JK, Severi G, Hodge AM, Baglietto L, Hopper JL, English DR, Giles GG (2013) Dietary intake of B vitamins and methionine and colorectal cancer risk. Nutr cancer 65(5):659–667.  https://doi.org/10.1080/01635581.2013.789114 CrossRefGoogle Scholar
  33. 33.
    Yoon YS, Jung S, Zhang X, Ogino S, Giovannucci EL, Cho E (2016) Vitamin B2 intake and colorectal cancer risk; results from the Nurses’ Health Study and the Health Professionals Follow-Up Study cohort. Int J Cancer 139(5):996–1008.  https://doi.org/10.1002/ijc.30141 CrossRefGoogle Scholar
  34. 34.
    Sharp L, Little J, Brockton NT, Cotton SC, Masson LF, Haites NE, Cassidy J (2008) Polymorphisms in the methylenetetrahydrofolate reductase (MTHFR) gene, intakes of folate and related B vitamins and colorectal cancer: a case–control study in a population with relatively low folate intake. Br J Nutr 99(2):379–389.  https://doi.org/10.1017/S0007114507801073 CrossRefGoogle Scholar
  35. 35.
    Curtin K, Samowitz WS, Ulrich CM, Wolff RK, Herrick JS, Caan BJ, Slattery ML (2011) Nutrients in folate-mediated, one-carbon metabolism and the risk of rectal tumors in men and women. Nutr cancer 63(3):357–366.  https://doi.org/10.1080/01635581.2011.535965 CrossRefGoogle Scholar
  36. 36.
    van Lee L, Heyworth J, McNaughton S, Iacopetta B, Clayforth C, Fritschi L (2011) Selected dietary micronutrients and the risk of right- and left-sided colorectal cancers: a case–control study in Western Australia. Ann Epidemiol 21(3):170–177.  https://doi.org/10.1016/j.annepidem.2010.10.005 CrossRefGoogle Scholar
  37. 37.
    Key TJ, Appleby PN, Masset G, Brunner EJ, Cade JE, Greenwood DC, Stephen AM, Kuh D, Bhaniani A, Powell N, Khaw KT (2012) Vitamins, minerals, essential fatty acids and colorectal cancer risk in the United Kingdom Dietary Cohort Consortium. Int J Cancer 131(3):E320–325.  https://doi.org/10.1002/ijc.27386 CrossRefGoogle Scholar
  38. 38.
    Morita M, Yin G, Yoshimitsu S, Ohnaka K, Toyomura K, Kono S, Ueki T, Tanaka M, Kakeji Y, Maehara Y, Okamura T, Ikejiri K, Futami K, Maekawa T, Yasunami Y, Takenaka K, Ichimiya H, Terasaka R (2013) Folate-related nutrients, genetic polymorphisms, and colorectal cancer risk: the fukuoka colorectal cancer study. Asian Pac J Cancer Prev 14(11):6249–6256CrossRefGoogle Scholar
  39. 39.
    Weinstein SJ, Albanes D, Selhub J, Graubard B, Lim U, Taylor PR, Virtamo J, Stolzenberg-Solomon R (2008) One-carbon metabolism biomarkers and risk of colon and rectal cancers. Cancer Epidemiol Prev Biomark 17(11):3233–3240CrossRefGoogle Scholar
  40. 40.
    Eussen SJ, Vollset SE, Hustad S, Midttun O, Meyer K, Fredriksen A, Ueland PM, Jenab M, Slimani N, Boffetta P, Overvad K, Thorlacius-Ussing O, Tjonneland A, Olsen A, Clavel-Chapelon F, Boutron-Ruault MC, Morois S, Weikert C, Pischon T, Linseisen J, Kaaks R, Trichopoulou A, Zilis D, Katsoulis M, Palli D, Pala V, Vineis P, Tumino R, Panico S, Peeters PH, Bueno-de-Mesquita HB, van Duijnhoven FJ, Skeie G, Munoz X, Martinez C, Dorronsoro M, Ardanaz E, Navarro C, Rodriguez L, VanGuelpen B, Palmqvist R, Manjer J, Ericson U, Bingham S, Khaw KT, Norat T, Riboli E (2010) Plasma vitamins B2, B6, and B12, and related genetic variants as predictors of colorectal cancer risk. Cancer Epidemiol Biomarkers Prev 19(10):2549–2561.  https://doi.org/10.1158/1055-9965.epi-10-0407
  41. 41.
    Otten JJ, Hellwig JP, Meyers LD (2006) Dietary reference intakes: the essential guide to nutrient requirements. National Academies PressGoogle Scholar
  42. 42.
    Hubner RA, Houlston RS (2007) MTHFR C677T and colorectal cancer risk: a meta-analysis of 25 populations. Int J Cancer 120(5):1027–1035.  https://doi.org/10.1002/ijc.22440 CrossRefGoogle Scholar
  43. 43.
    Webster RP, Gawde MD, Bhattacharya RK (1996) Modulation of carcinogen-induced DNA damage and repair enzyme activity by dietary riboflavin. Cancer Lett 98(2):129–135CrossRefGoogle Scholar
  44. 44.
    Ulrich CM (2005) Nutrigenetics in cancer research–folate metabolism and colorectal cancer. J Nutr 135(11):2698–2702CrossRefGoogle Scholar
  45. 45.
    Aili A, Hasim A, Kelimu A, Guo X, Mamtimin B, Abudula A, Upur H (2013) Association of the plasma and tissue riboflavin levels with C20orf54 expression in cervical lesions and its relationship to HPV16 infection. PloS One 8(11):e79937.  https://doi.org/10.1371/journal.pone.0079937 CrossRefGoogle Scholar
  46. 46.
    Agnoli C, Grioni S, Krogh V, Pala V, Allione A, Matullo G, Di Gaetano C, Tagliabue G, Pedraglio S, Garrone G, Cancarini I, Cavalleri A, Sieri S (2016) Plasma riboflavin and vitamin B-6, but not homocysteine, folate, or vitamin B-12, are inversely associated with Breast Cancer Risk in the European Prospective Investigation into Cancer and Nutrition-Varese Cohort. J Nutr 146(6):1227–1234.  https://doi.org/10.3945/jn.115.225433 CrossRefGoogle Scholar
  47. 47.
    Akimoto M, Sato Y, Okubo T, Todo H, Hasegawa T, Sugibayashi K (2006) Conversion of FAD to FMN and riboflavin in plasma:effects of measuring method. Biol Pharm Bull 29(8):1779–1782CrossRefGoogle Scholar

Copyright information

© Springer-Verlag GmbH Germany, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Department of Environmental Genomics, Jiangsu Key Laboratory of Cancer Biomarkers, Prevention and Treatment, Collaborative Innovation Center for Cancer Personalized MedicineNanjing Medical UniversityNanjingChina
  2. 2.Department of Genetic Toxicology, The Key Laboratory of Modern Toxicology of Ministry of Education, School of Public HealthNanjing Medical UniversityNanjingChina
  3. 3.School of Public HealthNantong UniversityNantongChina
  4. 4.School of Traditional Chinese PharmacyChina Pharmaceutical UniversityNanjingChina
  5. 5.Department of Statistics, School of EconomicsNanjing University of Finance and EconomicsNanjingChina
  6. 6.Department of Medical Oncology, Jiangsu Cancer Hospital, Jiangsu Institute of Cancer ResearchThe Affiliated Cancer Hospital of Nanjing Medical UniversityNanjingChina
  7. 7.Department of Oncology, Nanjing First HospitalNanjing Medical UniversityNanjingChina

Personalised recommendations